ロード中...
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
BACKGROUND/AIMS: We compared the efficacies of entecavir (ETV) plus tenofovir (TDF) and ETV plus adefovir (ADV) in chronic hepatitis B (CHB) patients with genotypic resistance to lamivudine (LAM) who showed a suboptimal response to LAM and ADV combination therapy. METHODS: We reviewed 63 CHB patient...
保存先:
| 出版年: | Clin Mol Hepatol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Association for the Study of the Liver
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4612285/ https://ncbi.nlm.nih.gov/pubmed/26523269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2015.21.3.242 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|